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Abstract 
Background: Leptospirosis and dengue are endemic in countries with subtropical or tropical climates and have epi-
demic potential. The incidence of both these diseases peaks during monsoons and both diseases present with similar 
clinical manifestations making differentiation of leptospirosis from dengue difficult. It is important to distinguish lep-
tospirosis from dengue as early antibiotic therapy in leptospirosis leads to a favourable outcome, while dengue has no 
specific treatment, yet early recognition is vital for close monitoring and careful fluid management. Despite the high 
prevalence of both these infections, co-infection of leptospirosis and dengue has not been reported previously in Sri 
Lanka. We present the first case of co-infection with leptospirosis and dengue in a Sri Lankan male.
Case presentation: A 52 year old previously healthy Sri Lankan male was admitted to our facility with a history 
of fever for 4 days associated with headache, generalized myalgia, reduced urine output. On examination, he was 
rational, hypotensive, tacycardic, tacypneic and he did not have clinical evidence of fluid leakage or pneumonitis. His 
serology showed high titre of dengue IgG and IgM and rising titre of leptospirosis antibody. His course of illness was 
complicated with septic shock, acute renal failure, acute respiratory distress syndrome and disseminated intravascular 
coagulation and he succumbed to his illness on the eighth day of admission.
Conclusion: In areas where both leptospirosis and dengue are endemic, both infections should be include in the 
differential diagnosis when evaluating patients with acute febrile illness and should consider the possibility of co-
infection. Leptospirosis, being a condition having definitive antibiotic therapy, should always be ruled out even if 
the patient is positive for dengue serology in regions endemic to both these diseases as early initiation of antibiotic 
therapy can reduce mortality significantly.
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Background
Leptospirosis, a zoonotic infection and dengue, an arthro-
pod born viral infection, are endemic in countries with 
humid subtropical or tropical climates and have epi-
demic potential [1]. Both these infections have emerged as 
major public health problem in Sri Lanka in recent years 
[2]. Recently, Sri Lanka has experienced a string of wide-
spread dengue epidemics annually which has now become 
a hyperendemic with frequent reports of dengue hemor-
rhagic fever (DHF) and dengue shock syndrome (DSS) [3].
The incidence of both these diseases peaks during 
monsoons and both diseases present with similar clini-
cal manifestations making differentiation of leptospirosis 
from dengue difficult [4]. It is important to distinguish 
leptospirosis from dengue as early antibiotic therapy in 
leptospirosis leads to a favourable outcome, while dengue 
has no specific treatment, yet early recognition is vital for 
close monitoring and careful fluid management [5, 6].
Despite the high prevalence of both these infections, 
co-infection of leptospirosis and dengue has not been 
reported previously in Sri Lanka. We present the first 
case of co-infection with leptospirosis and dengue in a Sri 
Lankan male.
Case presentation
A 52  year old previously healthy Sri Lankan male was 
admitted to our facility with a history of fever for 4 days 
associated with headache, abdominal pain, generalized 
myalgia and reduced urine output. On admission he was 
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febrile, rational and nonicteric, with a blood pressure 
of 90/60  mmHg, pulse of 118 beats/min, breathing fre-
quency of 22/min and oxygen saturation of 97  % on 
room air. The liver was tender and palpable 3 cm below 
the right costal margin. He did not have clinical evidence 
of pneumonitis, pleural effusion, ascites. Laboratory 
investigations on admission showed thrombocytope-
nia with normal white cell count and increased levels of 
blood urea, serum creatinine, liver transaminases, pro-
thombin time, creatinine phosphokinase and trophonin 
I. Both IgG and IgM dengue antibody tests were posi-
tive indicating recent dengue infection. Serological tests 
for leptospirosis (microscopic agglutination test) was 
negative. The investigation results are summarized in 
Table 1. Despite adequate fluid resuscitation, the patient 
remained hypotensive and he was started on inotropes 
and vasopressors. He was started on ceftriaxone and 
transferred to an intensive care unit where haemodialysis 
was started due to worsening acidaemia and fluid over-
load. On the second day, he developed haemoptysis and 
chest X ray showed evidence of diffuse bilateral alveolar 
haemorrhages. Arterial blood gas analysis showed type 1 
respiratory failure. As the patient was in severe respira-
tory distress, he was placed on mechanical ventilation. 
Later his condition was further complicated by dissemi-
nated intravascular coagulation. Leptospirosis serol-
ogy was repeated on day 7 and it showed a rising titre of 
3,600, indicating recent leptospirosis infection. Despite 
aggressive management of septic shock, oliguric acute 
renal failure, acute respiratory distress syndrome and 
disseminated intravascular coagulation, the patient suc-
cumbed to his illness on the eighth day of admission.
Discussion
Leptospirosis and dengue are increasingly being rec-
ognized as a cause of acute febrile illness in tropics and 
subtropics, putting almost half of the world’s population 
at risk. Sri Lanka, with a population of 25 million, repre-
sents an endemic region for both leptospirosis and den-
gue infections due to the geographic and climatic aspects 
of the country and the socioeconomic characteristics of 
its population.
Dengue fever is currently the most important mos-
quito-borne viral infection of public health significance in 
Sri Lanka, with thousands of patients acquiring the infec-
tion each year [3]. Dengue fever is caused by any of the 
four dengue virus serotypes (DEN 1–4) which are closely 
related. Dengue virus serotypes 2 and 3 were the pre-
dominant circulating serotypes in Sri Lanka until 2009. 
However, since 2010, dengue serotype 1 has become 
the predominant serotype in Sri Lanka accounting for 
more than 95  % of dengue infections [3]. Leptospirosis 
is a zoonotic disease which is endemic in Sri Lanka. The 
reported annual incidence of leptospirosis in Sri Lanka 
is 5.4 cases/100,000 persons, the sixth highest incidence 
worldwide [7]. However, incidence rates are imprecise 
estimates because leptospirosis is easily confused with 
undifferentiated fever of other causes, and few cases are 
laboratory confirmed [8]. There have been a tremendous 
increase in the number of cases reported in the recent 
years, with 7,421 cases (incidence rate 36.7/100,000 pop-
ulation) and 207 deaths (case fatality ate 2.8 %) reported 
in 2008 [9].
Cases of dengue and leptospirosis were seen through-
out the year with incidence of both disease peak dur-
ing the monsoon leading to concurrent epidemics. The 
clinical manifestations of leptospirosis and dengue range 
from a mild self-limiting febrile illness to a severe and 
potentially fatal illness characterized by thrombocytope-
nia, bleeding, hepatitis with cholestatic jaundice, myosi-
tis and renal failure. The vast overlapping spectrum of 
symptomatic manifestations of dengue and leptospirosis 
makes the clinical diagnosis challenging for treating phy-
sicians when acute co-infection is present.
An Indian study revealed that 1.7  % of patients pre-
sented with acute febrile illness have co-infection with 
leptospirosis and dengue [4]. As Sri Lanka and India 
share common geographic, climatic and socio-demo-
graphic characteristics, a similar incidence of co-infec-
tion with leptospirosis and dengue can be expected 
in Sri Lanka as well. The fact that the co-infection 
with leptospirosis and dengue has not been previ-
ously reported in Sri Lanka is most probably due to 
Table 1 Laboratory investigations of case presentation
Days from  
admission
Day 1 Day 3 Day 5 Day 8 Reference 
value
Haemoglobin (g/L) 11.4 11.3 7.3 9.1 13–16
Haematocrit (%) 32.8 32.6 24.6 28.3 40–50
Platelets (×109/L) 23 9 36 121 150–450
White blood cells 
(×109/L)
8.7 16.8 23.1 28.6 4,000–10,000
CPK (u/L) 1,180 1,790 809 – 25–174
Serum creatinine 
(µmol/L)
288 405 378 426 0.6–1.2
Blood urea (mmol/L) 28.9 32.8 34.7 2.9–8.2
Sodium (mmol/L) 133 137 136 142 135–148
Potassium (mmol/L) 4.3 3.9 4.8 5.4 3.5–5.1
AST (u/L) 48 151 109 126 10–35
ALT (u/L) 49 74 88 92 10–40
Serum bilirubin 
(µmol/L)
84 230 690 837 5.1–22
INR 1.26 1.8 2.1 3.2 1–1.3
APTT 58 69 87.9 116 28–42
Page 3 of 3Wijesinghe et al. BMC Res Notes  (2015) 8:348 
under-diagnosis and under-reporting rather than the 
rarity of its occurrence.
Even though co-infection with leptospirosis and den-
gue carries a high mortality rate, early administration of 
appropriate antibiotics is important as it has been shown 
to reduce the duration and severity of leptospirosis [5]. 
Therefore, clinicians in areas where both leptospirosis 
and dengue are endemic should include both infections 
in the differential diagnosis when evaluating patients 
with acute febrile illness and should consider the possi-
bility of co-infection.
Conclusion
In areas where both leptospirosis and dengue are 
endemic, both infections should be include in the dif-
ferential diagnosis when evaluating patients with acute 
febrile illness and should consider the possibility of co-
infection. Leptospirosis, being a condition having defini-
tive antibiotic therapy, should always be ruled out even 
if the patient is positive for dengue serology in regions 
endemic to both these diseases as early initiation of anti-
biotic therapy can reduce mortality significantly.
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